UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis

Multiple sclerosis, 2006-02, Vol.12 (1), p.58-65

2006

Volltextzugriff (PDF)

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

Brain (London, England : 1878), 2000-04, Vol.123 (4), p.687-697

2000

Volltextzugriff (PDF)

Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules

Journal of neuropathology and experimental neurology, 2001-04, Vol.60 (4), p.320-327

2001

Volltextzugriff (PDF)

Cytokine secretion patterns in twins discordant for Type I diabetes

Diabetologia, 1999-09, Vol.42 (9), p.1080-1085

1999

Volltextzugriff (PDF)

Human cerebral endothelial cells are a potential source for bioactive BDNF

Cytokine, 2002-07, Vol.19 (2), p.55-58

2002

Volltextzugriff (PDF)

"Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy

Nervenarzt, 2015-12, Vol.86 (12), p.1528-1537

2015

Volltextzugriff (PDF)

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease

Diabetes (New York, N.Y.), 1997-02, Vol.46 (2), p.237-243

1997

Volltextzugriff (PDF)

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

CNS drugs, 2016-08, Vol.30 (8), p.749-760

2016

Volltextzugriff (PDF)

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet neurology, 2014-03, Vol.13 (3), p.247-256

2014

Volltextzugriff (PDF)

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Lancet neurology, 2013-12, Vol.12 (12), p.1141-1150

2013

Volltextzugriff (PDF)

Exogenous nitric oxide modulates cytokine production in human leukocytes

Life sciences (1973), 1999-09, Vol.65 (17), p.1787-1794

1999

Volltextzugriff (PDF)

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease

Diabetes (New York, N.Y.), 1997-02, Vol.46 (2), p.237-243

1997

Volltextzugriff (PDF)

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

Journal of neurology, 2008-10, Vol.255 (10), p.1449-1463

2008

Volltextzugriff (PDF)

Time is brain“ bei der schubförmigen Multiplen Sklerose: Aktuelle Behandlungskonzepte in der Immuntherapie

Nervenarzt, 2015-12, Vol.86 (12), p.1528-1537

2015

Volltextzugriff (PDF)

Characteristic gene expression profile of primary human cerebral endothelial cells

The FASEB journal, 2002-04, Vol.16 (6), p.589-591

2002

Volltextzugriff (PDF)

Interleukin-10 is a predominant cytokine in atopic dermatitis

Archives of dermatology (1960), 1996-09, Vol.132 (9), p.1133-1134

Kallmann, B. A.

1996

Volltextzugriff (PDF)

Multiple Sclerosis Decision Model (MSDM): Entwicklung eines Mehrfaktorenmodells zur Beurteilung des Therapie- und Krankheitsverlaufs bei schubförmiger Multipler Sklerose

Aktuelle Neurologie, 2013-11, Vol.40 (9), p.486-493

2013

Volltextzugriff (PDF)

Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS): A two year follow-up study

Journal of neurology, 2004, Vol.251 (1), p.30-34

2004

Volltextzugriff (PDF)

Time is brain“ bei der schubförmigen Multiplen Sklerose: Aktuelle Behandlungskonzepte in der Immuntherapie

Psychopraxis neuropraxis, 2016-09, Vol.19 (4), p.131-140

2016

Volltextzugriff (PDF)

Exploring the neuro-vascular niche as potential target for treatment in MS

Multiple sclerosis, 2008-09, Vol.14, p.S88-S88

2008

Volltextzugriff (PDF)

Beneficial effects of pregnancy in multiple sclerosis reflected by cytokine pattern and prolactin

Multiple sclerosis, 2008-09, Vol.14, p.S241-S241

2008

Volltextzugriff (PDF)

Injektionshilfen in der Basistherapie der Multiplen Sklerose: Erhebung bei Neurologen, MS-Betreuern und Patienten

Nervenheilkunde, 2010, Vol.29 (1/02), p.57-62

2010

Volltextzugriff (PDF)

Was gibt es Neues in der multiplen Sklerose?

Aktuelle Neurologie, 2003-11, Vol.30 (9), p.421-427

2003

Volltextzugriff (PDF)

Interleukin-10 is a predominant cytokine in atopic dermatitis

Archives of dermatology (1960), 1996-09, Vol.132 (9), p.1133

1996

Volltextzugriff (PDF)

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

Multiple sclerosis, 2002-12, Vol.8 (6), p.523-526

2002

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules

Cytokine secretion patterns in twins discordant for Type I diabetes

Human cerebral endothelial cells are a potential source for bioactive BDNF

"Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Exogenous nitric oxide modulates cytokine production in human leukocytes

Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease

Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations

Time is brain“ bei der schubförmigen Multiplen Sklerose: Aktuelle Behandlungskonzepte in der Immuntherapie

Characteristic gene expression profile of primary human cerebral endothelial cells

Interleukin-10 is a predominant cytokine in atopic dermatitis

Multiple Sclerosis Decision Model (MSDM): Entwicklung eines Mehrfaktorenmodells zur Beurteilung des Therapie- und Krankheitsverlaufs bei schubförmiger Multipler Sklerose

Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS): A two year follow-up study

Time is brain“ bei der schubförmigen Multiplen Sklerose: Aktuelle Behandlungskonzepte in der Immuntherapie

Exploring the neuro-vascular niche as potential target for treatment in MS

Beneficial effects of pregnancy in multiple sclerosis reflected by cytokine pattern and prolactin

Injektionshilfen in der Basistherapie der Multiplen Sklerose: Erhebung bei Neurologen, MS-Betreuern und Patienten

Was gibt es Neues in der multiplen Sklerose?

Interleukin-10 is a predominant cytokine in atopic dermatitis

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters

Suchergebnisse filtern